Francesco Maura: Why myeloma relapses after anti-CD38 antibodies
Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center, shared a post on X:
“Happy to see our new story today on Blood Cancer Journal! We integrated Whole-genome sequencing (WGS) and immune profiling to explore why myeloma relapses after anti-CD38 antibodies.
Great collaboration with The University of Turin, The University of Milan, Sylvester Comprehensive Cancer Center, University of Miami, The National Cancer Institute of Milan and funded by AIRC Foundation for Cancer Research in Italy.
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
Autors: Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva , Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura and Alessandra Larocca
Here is the link to this work: Kudos to all the Authors in particular Bachisio Ziccheddu, Giannotta C, Mattia D’Agostino, Massaia M, Larocca A. Thanks for this fantastic collaboration.
For more details about our findings, you can check Bachisio Ziccheddu previous twittorial.”
Source: Francesco Maura/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023